American Board of Physical Medicine and Rehabilitation Medicine Examination Outline Approximate Target Weights Class I: Type of Problem/Organ System

A. by severity (15%) E. Rehabilitation problems and outcomes (40%) 1. Mild () 1. Neurological complications a. Sports a. Spasticity b. Nonsports b. Hydrocephalus c. Repetitive c. Seizures 2. Moderate d. Posture and balance disorders 3. Severe e. Movement disorders a. f. Gait disorders b. Minimally conscious g. Dysphagia and aspiration c. Vegetative state h. Paralysis and weakness 4. Brain death 2. Physical complications a. Contracture B. Traumatic brain injury by pattern (7%) b. Pressure ulcers 1. Penetrating c. Bed rest and deconditioning 2. Closed d. Fatigue a. Focal 3. Cognitive and sensory dysfunction b. Diffuse axonal injury a. Executive function c. b. Speech and language 3. Blast injury c. Hearing impairment d. Anosmia C. Other neurologic disorders (12%) e. Vestibular dysfunction 1. Dual diagnosis – TBI and f. Visual dysfunction 2. Ischemia g. Attention/memory/amnesia 3. Hemorrhage h. Agnosia 4. Anoxia i. Sleep disorders 5. Infectious 4. Behavioral disorders 6. Autoimmune a. Impulse control (inc sexuality, violence, aggression) 7. Endocrine/metabolic syndromes b. Agitation/restlessness 8. Tumor c. Lability

d. Apathy D. Systemic manifestations (19%) 5. Psychiatric/psychological 1. Cardiovascular a. Mood disorders a. Cardiac disorders b. Substance abuse b. Vascular disorders/injury c. Dementia or pseudodementia c. Hypertension/autonomic dysfunction d. Posttraumatic stress disorder 2. Pulmonary e. Other psych (inc suicide, personality disorders, anxiety) a. Pneumonia 6. Pain b. Tracheostomy care a. Headache 3. GU/GI b. Complex regional pain syndrome a. Bladder c. Myofascial pain b. Bowel c. Sexuality/reproduction F. Basic science (7%) 4. Soft tissue and orthopedic conditions a. Heterotopic ossification b. Fractures c. Soft tissue and nerve 5. Endocrine/metabolic/hormonal 6. Nutrition issues

American Board of Physical Medicine and Rehabilitation Brain Injury Medicine Examination Outline, page 2 Class II: Focus of Question/Patient Management

A. Patient evaluation and diagnosis (28%) 5. Equipment and assistive technology 1. Physical examination, signs, and symptoms a. Assistive technology (inc augmentative communication, 2. Diagnosis and etiology environmental controls) 3. Diagnostic procedures b. Orthoses, casting, splinting a. Gait analysis c. Mobility aids b. Lab studies 6. Behavioral/psychological/environmental c. Cerebrospinal fluid analysis a. Behavioral modification d. Neuroimaging b. Psychotherapy/counseling e. Musculoskeletal and other imaging c. Family issues (inc parenting) 4. Functional evaluation d. Cognitive rehabilitation therapy a. Assessment scales e. Biofeedback b. Outcome and functional scales f. Environmental modification c. Neuropsychological testing 7. Reintegration 5. Electrodiagnosis a. Vocational a. Electroencephalogram b. Educational b. Evoked potentials c. Avocational c. Peripheral nerve testing d. Resource allocation e. Family systems B. Prognosis/risk factors (12%) f. Driving 1. Premorbid 8. Complementary/alternative therapies 2. Injury‐related 9. Ethics, legal, capacity issues, advocacy 3. Treatment‐related (inc safety) D. Applied science (10%) C. Patient management (50%) 1. Anatomy 1. Clinical decision‐making a. Cortex 2. Therapeutic exercise b. Subcortical a. Motor control c. Brainstem/cranial nerves b. Mobility and range of motion d. Cerebellum c. Strength and endurance e. Peripheral nerves d. Functional electrical stimulation f. Musculoskeletal e. Exercise/activity 2. Physiology 3. Pharmacologic interventions 3. Pathology a. Analgesics 4. Kinesiology and biomechanics b. Anticonvulsants 5. Genetics, biomarkers, and proteomics c. Antispasticity agents (oral, IM) 6. Epidemiology and public health/prevention d. Antibiotics 7. Nutrition e. Sedatives/hypnotics 8. Research and statistics f. Stimulants 9. Growth, development, and aging g. Antidepressants h. Antipsychotics i. Anxiolytics, mood stabilizers j. Cognitive enhancers k. Antifatigue agents 4. Procedural/interventional a. monitoring b. Surgery c. Neuromodulation (inc intrathecal therapies and central/peripheral nervous system stimulation)

6/5/2014